Natco Pharma

Historical price data

Natco Pharma Limited is a vertically integrated pharmaceutical company with a mission to improve patient access to high-quality, affordable medicines. The company has established itself as a leader in the Indian generics market, with significant achievements in developing and commercializing complex generics, including oncology drugs like lenalidomide and hepatitis C treatments. Its strategic direction focuses on expanding its branded generics portfolio, strengthening its API business, and pursuing growth in regulated markets like the US through its subsidiary Natco Pharma USA.

Core expertise in complex generic drug development and API synthesis, focusing on reverse engineering, robust process chemistry, and regulatory filings for high-barrier-to-entry pharmaceuticals.

1 drug in pipeline

Competes with large Indian generic firms (Sun Pharma, Dr. Reddy's, Cipla) and global generics leaders (Teva, Viatris). Differentiation is achieved through a strategic focus on high-barrier complex generics, a strong API backbone, and a proven track record of successful patent challenges to secure early market entry.